InvestorsHub Logo
Post# of 176381
Next 10
Followers 7
Posts 932
Boards Moderated 1
Alias Born 06/17/2019

Re: None

Thursday, 09/28/2023 8:48:07 PM

Thursday, September 28, 2023 8:48:07 PM

Post# of 176381
Friendly reminder that even tho this quote is a little out of date now, this number has only gotten better based on recent advancements in Isopet and treatments.

We reviewed all the commercial IsoPet® therapy cases over the last three years. We determined that, even though we treated several very advanced tumors, they had an approximate 65% Complete Response (CR) using the official RICIST criteria. This demonstrates that IsoPet® is an effective tool. We are currently directing efforts to increase the number of regional clinics and the number of new patients.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News